Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue-Reference-Cited by-同舟云学术

Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue

Published:2024-05-27 Issue:9 Volume:20 Page:2076-2091
ISSN:1554-8627
Container-title:Autophagy
language:en
Short-container-title:Autophagy

Author:

Watzlawik Jens O.¹^ORCID,Hou Xu¹^ORCID,Richardson Tyrique¹,Lewicki Szymon L.¹,Siuda Joanna²,Wszolek Zbigniew K.³,Cook Casey N.¹⁴,Petrucelli Leonard¹⁴,DeTure Michael¹,Dickson Dennis W.¹⁴,Antico Odetta⁵,Muqit Miratul M. K.⁵,Fishman Jordan B.⁶,Pirani Karima⁷,Kumaran Ravindran⁸,Polinski Nicole K.⁹,Fiesel Fabienne C.¹⁴^ORCID,Springer Wolfdieter¹⁴^ORCID

Affiliation:

1. Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA

2. Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland

3. Department of Neurology, Mayo Clinic, Jacksonville, FL, USA

4. Neuroscience PhD Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA

5. MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, UK

6. 21st Century Biochemicals Inc, Marlborough, MA, USA

7. ImmunoPrecise Antibodies Ltd, Victoria, BC, Canada

8. Abcam plc, Cambridge, UK

9. The Michael J. Fox Foundation for Parkinson’s Research, New York, NY, USA

Funder

National Institute of Neurological Disorders and Stroke